Ameliorating effects of preadolescent aniracetam treatment on prenatal ethanol-induced impairment in AMPA receptor activity

Neurobiology of Disease

Volumn 29, Issue 1, 2008, Pages 81-91

  Wijayawardhane, Nayana ^a   Shonesy, Brian C ^a   Vaithianathan, Thirumalini ^a,b   Pandiella, Noemi ^a   Vaglenova, Julia ^a   Breese, Charles R ^a,c   Dityatev, Alexander ^a,d   Suppiramaniam, Vishnu ^a  

^a AUBURN UNIVERSITY   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c University of Appalachia College of Pharmacy   (United States)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

AMPA receptors; Aniracetam; Fetal alcohol spectrum disorder; Hippocampus; Prenatal ethanol; Single channel recording; Synaptic transmission; Whole cell recording

Indexed keywords

ALCOHOL; AMPA RECEPTOR; ANIRACETAM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXCITATORY POSTSYNAPTIC POTENTIAL; NONHUMAN; PRENATAL PERIOD; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DRUG INTERACTIONS; ETHANOL; EXCITATORY AMINO ACID AGENTS; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; HIPPOCAMPUS; ION CHANNEL GATING; NEURONS; NOOTROPIC AGENTS; PATCH-CLAMP TECHNIQUES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; TIME FACTORS;

EID: 36549032214     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2007.08.001     Document Type: Article

References (54)

1. Abel E., and Sokol R. Fetal alcohol syndrome is now leading cause of mental retardation. Lancet 2 (1986) 1222
2. Arai A., and Lynch G. AMPA receptor desensitization modulates synaptic responses induced by repetitive afferent stimulation in hippocampal slices. Brain Res. 799 (1998) 235-242
3. Arai A.C., Kessler M., Rogers G., and Lynch G. Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466. Mol. Pharmacol. 58 (2000) 802-813
4. Barnes D.E., and Walker D.W. Prenatal ethanol exposure permanently reduces the number of pyramidal neurons in rat hippocampus. Brain Res. 227 (1981) 333-340
5. Bartolini L., Casamenti F., and Pepeu G. Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. Pharmacol. Biochem. Behav. 53 (1996) 277-283
6. Bearer C.F., Swick A.R., O'Riordan M.A., and Cheng G. Ethanol inhibits L1-mediated neurite outgrowth in postnatal rat cerebellar granule cells. J. Biol. Chem. 274 (1999) 13264-13270
7. Breese C.R., D'Costa A., Ingram R.L., Lenham J., and Sonntag W.E. Long-term suppression of insulin-like growth factor-1 in rats after in utero ethanol exposure: relationship to somatic growth. J. Pharmacol. Exp. Ther. 264 (1993) 448-456
8. Charness M.E., Safran R.M., and Perides G. Ethanol inhibits neural cell-cell adhesion. J. Biol. Chem. 269 (1994) 9304-9309
9. Chavez G.F., Cordero J.F., and Becerra J.E. Leading major congenital malformations among minority groups in the United States, 1981-1986. MMWR Morb. Mortal. Wkly. Rep. 37 (1988) 17-24
10. Coles C.D., Brown R.T., Smith I.E., Platzman K.A., Erickson S., and Falek A. Effects of prenatal alcohol exposure at school age: I. Physical and cognitive development. Neurotoxicol. Teratol. 13 (1991) 357-367
11. Coper H., and Herrmann W.M. Psychostimulants, analeptics, nootropics: an attempt to differentiate and assess drugs designed for the treatment of impaired brain functions. Pharmacopsychiatry 21 (1988) 211-217
12. Costa E.T., Savage D.D., and Valenzuela C.F. A review of the effects of prenatal or early postnatal ethanol exposure on brain ligand-gated ion channels. Alcohol., Clin. Exp. Res. 24 (2000) 706-715
13. Cumin R., Bandle E.F., Gamzu E., and Haefely W.E. Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents. Psychopharmacology (Berlin) 78 (1982) 104-111
14. Deltour L., Ang H.L., and Duester G. Ethanol inhibition of retinoic acid synthesis as a potential mechanism for fetal alcohol syndrome. FASEB J. 10 (1996) 1050-1057
15. Farr K.L., Montano C.Y., Paxton L.L., and Savage D.D. Prenatal ethanol exposure decreases hippocampal 3H-glutamate binding in 45-day-old rats. Alcohol 5 (1988) 125-133
16. Giurgea C. A drug for the mind. Chem. Technol. 10 (1980) 360-365
17. Gomes A.R., Correia S.S., Carvalho A.L., and Duarte C.B. Regulation of AMPA receptor activity, synaptic targeting and recycling: role in synaptic plasticity. Neurochem. Res. 28 (2003) 1459-1473
18. Gouliaev A.H., and Senning A. Piracetam and other structurally related nootropics. Brain Res. Brain Res. Rev. 19 (1994) 180-222
19. Gruol D.L., Ryabinin A.E., Parsons K.L., Cole M., Wilson M.C., and Qiu Z. Neonatal alcohol exposure reduces NMDA induced Ca2+ signaling in developing cerebellar granule neurons. Brain Res. 793 (1998) 12-20
20. Guerri C. Neuroanatomical and neurophysiological mechanisms involved in central nervous system dysfunctions induced by prenatal alcohol exposure. Alcohol., Clin. Exp. Res. 22 (1998) 304-312
21. Heaton M.B., Paiva M., Swanson D.J., and Walker D.W. Prenatal ethanol exposure alters neurotrophic activity in the developing rat hippocampus. Neurosci. Lett. 188 (1995) 132-136
22. Ingvar M., Ambros-Ingerson J., Davis M., Granger R., Kessler M., Rogers G.A., Schehr R.S., and Lynch G. Enhancement by an ampakine of memory encoding in humans. Exp. Neurol. 146 (1997) 553-559
23. Isaacson J.S., and Nicoll R.A. Aniracetam reduces glutamate receptor desensitization and slows the decay of fast excitatory synaptic currents in the hippocampus. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 10936-10940
24. Johnson M.W., Chotiner J.K., and Watson J.B. Isolation and characterization of synaptoneurosomes from single rat hippocampal slices. J. Neurosci. Methods 77 (1997) 151-156
25. Keshavarzian A., Choudhary S., Holmes E.W., Yong S., Banan A., Jakate S., and Fields J.Z. Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J. Pharmacol. Exp. Ther. 299 (2001) 442-448
26. Lawrence J.J., Brenowitz S., and Trussell L.O. The mechanism of action of aniracetam at synaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors: indirect and direct effects on desensitization. Mol. Pharmacol. 64 (2003) 269-278
27. Lu Y., and Wehner J.M. Enhancement of contextual fear-conditioning by putative (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor modulators and N-methyl-d-aspartate (NMDA) receptor antagonists in DBA/2J mice. Brain Res. 768 (1997) 197-207
28. Lucchi L., Pascale A., Battaini F., Govoni S., and Trabucchi M. Cognition stimulating drugs modulate protein kinase C activity in cerebral cortex and hippocampus of adult rats. Life Sci. 53 (1993) 1821-1832
29. Maier S.E., and West J.R. Drinking patterns and alcohol-related birth defects. Alcohol Res. Health 25 (2001) 168-174
30. Morrisett R.A., Martin D., Wilson W.A., Savage D.D., and Swartzwelder H.S. Prenatal exposure to ethanol decreases the sensitivity of the adult rat hippocampus to N-methyl-d-aspartate. Alcohol 6 (1989) 415-420
31. O'Neill M.J., Bleakman D., Zimmerman D.M., and Nisenbaum E.S. AMPA receptor potentiators for the treatment of CNS disorders. Curr. Drug Targets CNS Neurol. Disord. 3 (2004) 181-194
32. Pandiella, N.M., Wijayawardhane, K.A.N., Birru, S., Breese, C.R., Suppiramaniam, V., Vaglenova, J., 2005. Aniracetam, a potential therepeutic egent in reversing learning and memory deficits caused by prenatal ethanol exposure. (Abstract) Society for Neuroscience Program No. 884.17.
33. Partin K.M., Fleck M.W., and Mayer M.L. AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate. J. Neurosci. 16 (1996) 6634-6647
34. Perrone-Bizzozero N.I., Isaacson T.V., Keidan G.M., Eriqat C., Meiri K.F., Savage D.D., and Allan A.M. Prenatal ethanol exposure decreases GAP-43 phosphorylation and protein kinase C activity in the hippocampus of adult rat offspring. J. Neurochem. 71 (1998) 2104-2111
35. Petkov V.D., Konstantinova E.R., Petkov V.V., and Vaglenova J.V. Learning and memory in rats exposed pre- and postnatally to alcohol. An attempt at pharmacological control. Methods Find. Exp. Clin. Pharmacol. 13 (1991) 43-50
36. Pontecorvo M.J., and Evans H.L. Effects of aniracetam on delayed matching-to-sample performance of monkeys and pigeons. Pharmacol. Biochem. Behav. 22 (1985) 745-752
37. Smith A.M., and Wehner J.M. Aniracetam improves contextual fear conditioning and increases hippocampal gamma-PKC activation in DBA/2J mice. Hippocampus 12 (2002) 76-85
38. Spear L. Modeling adolescent development and alcohol use in animals. Alcohol Res. Health 24 (2000) 115-123
39. Spignoli G., and Pepeu G. Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine. Pharmacol. Biochem. Behav. 27 (1987) 491-495
40. Staubli U., Rogers G., and Lynch G. Facilitation of glutamate receptors enhances memory. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 777-781
41. Sun Y., Olson R., Horning M., Armstrong N., Mayer M., and Gouaux E. Mechanism of glutamate receptor desensitization. Nature 417 (2002) 245-253
42. Tang C.M., Shi Q.Y., Katchman A., and Lynch G. Modulation of the time course of fast EPSCs and glutamate channel kinetics by aniracetam. Science 254 (1991) 288-290
43. Toide K. Effects of aniracetam on one-trial passive avoidance tests and cholinergic neurons in discrete brain regions of rats. Arch. Int. Pharmacodyn. Ther. 298 (1989) 25-37
44. Vaglenova J., and Vesselinov-Petkov V. Can nootropic drugs be effective against the impact of ethanol teratogenicity on cognitive performance?. Eur. Neuropsychopharmacol. 11 (2001) 33-40
45. Vaglenova, J., Pandiella, N., Wijayawardhane, N., Vaithianathan, T., Birru, S., Breese, C., Suppiramaniam, V., Randal, C., in press. Aniracetam reversed learning and memory deficits following prenatal ethanol exposure by modulating functions of synaptic AMPA receptors. Neuropsychopharmacology, doi:10.1038/sj.npp.1301496 (4 July 2007).
46. Vaithianathan T., Manivannan K., Kleene R., Bahr B.A., Dey M.P., Dityatev A., and Suppiramaniam V. Single channel recordings from synaptosomal AMPA receptors. Cell Biochem. Biophys. 42 (2005) 75-85
47. Vincent G., Verderese A., and Gamzu E. The effects of aniracetam (Ro 13-5057) on the enhancement and protection of memory. Ann. N. Y. Acad. Sci. 444 (1985) 489-491
48. Vyklicky Jr. L., Patneau D.K., and Mayer M.L. Modulation of excitatory synaptic transmission by drugs that reduce desensitization at AMPA/kainate receptors. Neuron 7 (1991) 971-984
49. Wainwright P.E. Issues of design and analysis relating to the use of multiparous species in developmental nutritional studies. J. Nutr. 128 (1998) 661-663
50. Weaver M.S., Lee Y.H., Morris J.L., Randall P.K., Schallert T., and Leslie S.W. Effects of in vitro ethanol and fetal ethanol exposure on glutathione stimulation of N-methyl-d-aspartate receptor function. Alcohol., Clin. Exp. Res. 17 (1993) 643-650
51. Wijayawardhane N., Shonesy B.C., Vaglenova J., Vaithianathan T., Carpenter M., Breese C.R., Dityatev A., and Suppiramaniam V. Postnatal aniracetam treatment improves prenatal ethanol induced attenuation of AMPA receptor mediated synaptic transmission. Neurobiol. Dis. 26 (2007) 696-706
52. Zeng X.J., and Tietz E.I. Benzodiazepine tolerance at GABAnergic synapses on hippocampal CA1 pyramidal cells. Synapse 31 (1999) 263-277
53. Zeng X., Xie X.H., and Tietz E.I. Reduction of GABA-mediated inhibitory postsynaptic potentials in hippocampal CA1 pyramidal neurons following oral flurazepam administration. Neuroscience 66 (1995) 87-99
54. Zivkovic I., Thompson D.M., Bertolino M., Uzunov D., DiBella M., Costa E., and Guidotti A. 7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating dl-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization. J. Pharmacol. Exp. Ther. 272 (1995) 300-309